BioLineRx Ltd. (BLRX.TA)
ILA 1.9
(5.56%)
ILA 1.9
(5.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -60.61 Million USD | -192.19% |
| 2022 | -20.74 Million USD | 26.29% |
| 2021 | -28.14 Million USD | 9.01% |
| 2020 | -30.93 Million USD | -15.39% |
| 2019 | -26.8 Million USD | -16.74% |
| 2018 | -22.96 Million USD | 5.71% |
| 2017 | -24.35 Million USD | -53.73% |
| 2016 | -15.84 Million USD | -10.01% |
| 2015 | -14.4 Million USD | -41.53% |
| 2014 | -10.17 Million USD | 42.33% |
| 2013 | -17.64 Million USD | 13.58% |
| 2012 | -20.41 Million USD | -54.82% |
| 2011 | -13.18 Million USD | -728.82% |
| 2010 | 2.09 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 484 Thousand USD | 169.54% |
| 2024 Q1 | -696 Thousand USD | 94.99% |
| 2023 Q4 | -13.88 Million USD | 13.35% |
| 2023 Q2 | -18.54 Million USD | -19.89% |
| 2023 FY | -60.61 Million USD | -192.19% |
| 2023 Q3 | -16.02 Million USD | 13.6% |
| 2023 Q1 | -15.46 Million USD | -404.83% |
| 2022 Q2 | -7.28 Million USD | -92.65% |
| 2022 Q3 | -6.61 Million USD | 9.17% |
| 2022 Q4 | -3.06 Million USD | 53.69% |
| 2022 FY | -20.74 Million USD | 26.29% |
| 2022 Q1 | -3.78 Million USD | 12.15% |
| 2021 Q1 | -10.19 Million USD | 14.98% |
| 2021 Q2 | -6.84 Million USD | 32.87% |
| 2021 Q4 | -4.3 Million USD | 24.7% |
| 2021 FY | -28.14 Million USD | 9.01% |
| 2021 Q3 | -5.71 Million USD | 16.46% |
| 2020 Q2 | -6.77 Million USD | -1.88% |
| 2020 Q4 | -11.98 Million USD | -159.59% |
| 2020 FY | -30.93 Million USD | -15.39% |
| 2020 Q3 | -4.61 Million USD | 31.79% |
| 2020 Q1 | -6.64 Million USD | 32.66% |
| 2019 Q2 | -5.48 Million USD | 10.89% |
| 2019 Q1 | -6.15 Million USD | -8.9% |
| 2019 FY | -26.8 Million USD | -16.74% |
| 2019 Q3 | -3.93 Million USD | 28.2% |
| 2019 Q4 | -9.86 Million USD | -150.58% |
| 2018 Q2 | -4.78 Million USD | 22.75% |
| 2018 FY | -22.96 Million USD | 5.71% |
| 2018 Q4 | -5.65 Million USD | 10.63% |
| 2018 Q3 | -6.32 Million USD | -32.08% |
| 2018 Q1 | -6.19 Million USD | 15.75% |
| 2017 Q2 | -4.89 Million USD | -0.87% |
| 2017 Q1 | -4.85 Million USD | -13.3% |
| 2017 FY | -24.35 Million USD | -53.73% |
| 2017 Q4 | -7.35 Million USD | -1.57% |
| 2017 Q3 | -7.24 Million USD | -47.91% |
| 2016 Q3 | -4.33 Million USD | -16.04% |
| 2016 FY | -15.84 Million USD | -10.01% |
| 2016 Q1 | -3.48 Million USD | 4.46% |
| 2016 Q2 | -3.73 Million USD | -7.05% |
| 2016 Q4 | -4.28 Million USD | 1.13% |
| 2015 FY | -14.4 Million USD | -41.53% |
| 2015 Q4 | -3.65 Million USD | -124.6% |
| 2015 Q3 | -1.62 Million USD | 66.2% |
| 2015 Q2 | -4.81 Million USD | -11.58% |
| 2015 Q1 | -4.31 Million USD | -17.94% |
| 2014 Q3 | -680.22 Thousand USD | 83.47% |
| 2014 Q2 | -4.11 Million USD | -94.7% |
| 2014 FY | -10.17 Million USD | 42.33% |
| 2014 Q1 | -2.11 Million USD | 55.32% |
| 2014 Q4 | -3.65 Million USD | -437.37% |
| 2013 Q2 | -4.26 Million USD | -21.43% |
| 2013 Q1 | -3.51 Million USD | 51.55% |
| 2013 Q4 | -4.72 Million USD | 4.49% |
| 2013 FY | -17.64 Million USD | 13.58% |
| 2013 Q3 | -4.95 Million USD | -16.02% |
| 2012 FY | -20.41 Million USD | -54.82% |
| 2012 Q3 | -5.73 Million USD | -98.4% |
| 2012 Q2 | -2.89 Million USD | 40.1% |
| 2012 Q1 | -4.82 Million USD | -34.97% |
| 2012 Q4 | -7.25 Million USD | -26.46% |
| 2011 Q1 | -3.32 Million USD | 44.31% |
| 2011 Q3 | -2.11 Million USD | 55.75% |
| 2011 Q4 | -3.57 Million USD | -68.71% |
| 2011 FY | -13.18 Million USD | -728.82% |
| 2011 Q2 | -4.79 Million USD | -44.09% |
| 2010 Q1 | -4.16 Million USD | 0.0% |
| 2010 Q2 | -7.25 Million USD | -73.95% |
| 2010 Q3 | 19.98 Million USD | 375.55% |
| 2010 Q4 | -5.96 Million USD | -129.87% |
| 2010 FY | 2.09 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Matricelf Ltd | -12.48 Million ILA | -385.456% |